Eye Cancer Treatment WVU (IMAGE)
Caption
Osama Elzamzamy—a graduate research assistant in the WVU Cancer Institute—conducts work in Lori Hazlehurst’s laboratory. Hazlehurst is the Cancer Institute’s associate director of basic research and a professor in the School of Pharmacy. She and her colleague Mark McLaughlin—a researcher with the Cancer Institute and School of Pharmacy professor—co-founded the company Modulation Therapeutics Inc., which recently received its first investigational new drug application from the Food and Drug Administration.
Credit
WVU Photo
Usage Restrictions
None
License
Original content